ASCO 2022: Breast cancer highlights

Updated data from the Phase 1/2 MajesTEC-1 study evaluating teclistamab, a BCMA x CD3 bispecific antibody

Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer

Panitumumab plus mFOLFOX6 improves OS for RAS wild-type left sided mCRC

High-dose ifosfamide standard of care for recurrent and primary refractory ewing sarcoma

ASCO and WHO to collaborate on quality indicators for cancer facilities

Cancer Services Delivery: Focus on India

Information sharing experiences of professionals looking after children with cancer

The role of the Global Coalition for Radiotherapy in the war in Ukraine

Youth Cancer Europe: Aiding Ukrainian refugees during the crisis

War in Ukraine: Impacts on the Slovakian cancer care system

Inspiration Family: Challenges of the Ukrainian cancer charity on the frontline